Industry Outlook

The vitamin D therapy market is set to reach US$ 6329.5 Mn by 2030 from US$ 2572.8 Mn in 2021 showcasing spectacular growth at a compounded annual growth rate (CAGR) of 10.6% during the forecast period from 2023 to 2030.  As per the research findings of International Osteoporosis Foundation (IOF), one in three women and one in five men above the age of 50 years is prone to suffer with fracture during their lifetime. Malnourishment, increasing consumption of alcohol & tobacco and hormonal imbalance are causing bone and skin disorders associated with vitamin D deficiency. 

"Excellent pharmacokinetic and pharmacodynamic drug profile will help parenteral route to register faster growth"

Oral route of administration is reigning the vitamin D therapy market in the present scenario. It is very popular in children due to ease of administration and formulated in different sizes and colors which increases its external aesthetic appeal hence increasing its palatability in childrens. It is also beneficial in improving vitamin D levels in adults with no systemic illness. Parenteral route are gaining traction on account of its inherent features such as excellent pharmacokinetic and pharmacodynamic drug profile useful in elderly patients suffering with impaired vitamin D absorption via the gastrointestinal tract. 

"Increasing consumption of diet deficient in vitamin D & calcium and hormonal imbalance causes osteoporosis with progressive ageing in humans"

Osteoporosis is currently dominating the applications segment for vitamin D therapy market. As per the latest statistics provided by International Osteoporosis Foundation (IOF), globally osteoporosis causes 8.9 million bone fracture occurring at every 3 seconds. The risk factors associated with osteoporosis is increasing consumption of diet efficient in calcium and Vitamin D and hormonal imbalance with progressive ageing in humans. The occurrence rate is high in female as compared to the male population. Malnutrition is causing rickets in children at an early age in the developing and poor countries. Skin disease are garnering huge traction on account of huge deletion of ozone layers causes the harmful UV radiation to skin surface depleting keratinocytes useful in Vitamin D3 synthesis in skin. Skin inflammatory diseases such as atopic dermatitis and psoriasis are associated with depleting levels of skin vitamin D levels.

"Rising prevalence of osteoporosis & low bone mass and increasing public health awareness drive the market growth in North America region"

North America is currently representing 33% market share in the regional segment for vitamin D therapy market. The major factors influencing its market growth are rising prevalence of osteoporosis and low bone mass. According to the research findings brought forward by National Osteoporosis Foundation (NOF), approximately one half of the total adult population in the United States is suffering with osteoporosis.  Increasing public health awareness in the region will further propel the market growth. Europe is in the second place holding 30% market share owing to rising prevalence of skin disorders associated with low serum cholecalciferol levels. Favorable reimbursement scenario associated with vitamin D therapy consolidates the market growth in European Region. Asia Pacific accounts for 20% market share primarily due to rising prevalence of malnutrition in children causing rickets at an early age. Presence of major players such as GlaxoSmithkline, Plc., Torrent Pharmaceuticals Ltd., Cadila Healthcare, Alkem Laboratories etc. drive the market growth in Asia Pacific region.

Pharmaceutical companies providing vitamin D therapy are Abbott Laboratories, Inc., Alkem Laboratories, Cadila Healthcare Ltd., GlaxoSmithkline, Plc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Torrent Pharmaceutical Ltd.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Vitamin D Therapy market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Vitamin D Therapy market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Vitamin D Therapy market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Vitamin D Therapy market?
• Which is the largest regional market for Vitamin D Therapy market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Vitamin D Therapy market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Vitamin D Therapy market worldwide?